Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET–Rearranged Lung Cancers Academic Article uri icon

Overview

MeSH Major

  • Autoantibodies
  • Carcinoma, Small Cell
  • Lung Neoplasms
  • Neurons
  • Paraneoplastic Syndromes

abstract

  • Brain metastases occur frequently in RET-rearranged lung cancers, and outcomes with multikinase inhibitor therapy in general are suboptimal. Novel RET-directed targeted therapy strategies are needed.

publication date

  • October 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jtho.2018.07.004

PubMed ID

  • 30017832

Additional Document Info

start page

  • 1595

end page

  • 1601

volume

  • 13

number

  • 10